Literature DB >> 23797752

Prognostic gene signatures for hepatocellular carcinoma: what are we measuring?

Kenneth K Tanabe, Yujin Hoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23797752      PMCID： PMC4005003          DOI： 10.1245/s10434-013-3071-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  11 in total

Review 1.  RNA sequencing: advances, challenges and opportunities.

Authors:  Fatih Ozsolak; Patrice M Milos
Journal:  Nat Rev Genet       Date:  2010-12-30       Impact factor: 53.242

2.  Direct multiplexed measurement of gene expression with color-coded probe pairs.

Authors:  Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

3.  Use of archived specimens in evaluation of prognostic and predictive biomarkers.

Authors:  Richard M Simon; Soonmyung Paik; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2009-10-08       Impact factor: 13.506

Review 4.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

Authors:  Augusto Villanueva; Yujin Hoshida; Carlo Battiston; Victoria Tovar; Daniela Sia; Clara Alsinet; Helena Cornella; Arthur Liberzon; Masahiro Kobayashi; Hiromitsu Kumada; Swan N Thung; Jordi Bruix; Philippa Newell; Craig April; Jian-Bing Fan; Sasan Roayaie; Vincenzo Mazzaferro; Myron E Schwartz; Josep M Llovet
Journal:  Gastroenterology       Date:  2011-02-12       Impact factor: 22.682

6.  New strategies in hepatocellular carcinoma: genomic prognostic markers.

Authors:  Augusto Villanueva; Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Clara Alsinet; Radoslav Savic; Helena Cornella; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2010-08-16       Impact factor: 12.531

Review 7.  Gene signatures in the management of hepatocellular carcinoma.

Authors:  Yujin Hoshida; Agrin Moeini; Clara Alsinet; Kensuke Kojima; Augusto Villanueva
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

8.  Molecular profiling to predict hepatocellular carcinoma outcome.

Authors:  Yujin Hoshida; Augusto Villanueva; Josep M Llovet
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 3.869

9.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

10.  Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment.

Authors:  Yujin Hoshida
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240
View more
  1 in total

1.  Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.

Authors:  Kensuke Kojima; Craig April; Claudia Canasto-Chibuque; Xintong Chen; Manjeet Deshmukh; Anu Venkatesh; Poh Seng Tan; Masahiro Kobayashi; Hiromitsu Kumada; Jian-Bing Fan; Yujin Hoshida
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.